Skip to main content
Clinical Trials/NCT03802812
NCT03802812
Completed
Not Applicable

Thin Bronchoscope and Virtual Bronchoscopic Navigation System for Rapid Detection of Mycobacterium Tuberculosis and Resistant-conferring Mutations

Pusan National University Hospital1 site in 1 country88 target enrollmentFebruary 1, 2019
ConditionsTuberculosis

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Tuberculosis
Sponsor
Pusan National University Hospital
Enrollment
88
Locations
1
Primary Endpoint
detection of M. tuberculosis and resistant-conferring mutations
Status
Completed
Last Updated
4 years ago

Overview

Brief Summary

This study investigates the utility of thin bronchoscope and virtual bronchoscopic navigation system (targeted bronchial washing) for detection of M. tuberculosis and resistant-conferring mutations in patients with pulmonary tuberculosis. Time to appropriate treatment and stain/culture conversion are also evaluated.

Detailed Description

Comparisons of detection rate of M. tuberculosis and resistant-conferring mutations between patients who perform CT-guided conventional bronchoscope and patients who perform VBN-guided thin bronchoscope.

Registry
clinicaltrials.gov
Start Date
February 1, 2019
End Date
April 19, 2022
Last Updated
4 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Jeongha Mok

Clinical Professor

Pusan National University Hospital

Eligibility Criteria

Inclusion Criteria

  • age of 18 or more
  • persons who are suspected with pulmonary tuberculosis on radiologic examination
  • persons who cannot spit sputum or persons with negative results on sputum AFB smear and TB-PCR or Xpert MTB/RIF assay

Exclusion Criteria

  • persons who do not agree with bronchoscopy (persons who want empirical treatment for TB)
  • persons with contraindications for bronchoscopy
  • bleeding tendency
  • uncontrolled respiratory disease (hypoxemia)
  • uncontrolled cardiovascular disease

Outcomes

Primary Outcomes

detection of M. tuberculosis and resistant-conferring mutations

Time Frame: 2months after procedure

evaulation by sensitivity, specificity, PPV and NPV

Secondary Outcomes

  • time to appropriate treatment and stain/culture conversion(6months after procedure)

Study Sites (1)

Loading locations...

Similar Trials